Interaction of AR and iNOS in lens epithelial cell: A new pathogenesis and potential therapeutic targets of diabetic cataract

详细信息    查看全文

• 作者：Xue Li^a ; ¹ ; ^{xiaoxuesnowflak@163.com} ; Wenping Liu^b ; ¹ ; ^{710304675@qq.com} ; Xinduo Huang^a ; ^{504782301@qq.com} ; Jianping Xiong^c ; ^{xiong@helix.mgh.harvard.edu} ; Xiaoyong Wei^a ; ^d ; ^{jidewowxy2@163.com}
• 关键词：Diabetic cataract ; Aldose reductase ; Inducible nitric oxide synthase ; Interaction
• 刊名：Archives of Biochemistry and Biophysics
• 出版年：2017
• 出版时间：1 February 2017
• 年：2017
• 卷：615
• 期：Complete
• 页码：44-52
• 全文大小：1509 K
• 卷排序：615

文摘

Although there is significant interest in revealing the role of aldose reductase (AR) and inducible nitric oxide synthase (iNOS) in diabetic cataract (DC), the interaction of AR and iNOS remains unknown. The aim of this study is to investigate the pathogenesis mechanisms and explore as a new potential therapeutic targets for DC. This study investigated the interaction of AR-iNOS through the methods of enzyme kinetics, molecular docking and molecular dynamics simulation, co-immunoprecipitation and fluorescence resonance energy transfer (FRET). The IC50 of AR for inhibition of iNOS activity is 0.04 μM, and the IC50 of iNOS for inhibition of AR activity is 0.042 μM through enzyme kinetics; the interface showed that ARG99 on AR and GLU317 on iNOS played the key roles in the interaction of AR-iNOS predicted by molecular docking and molecular dynamics simulation. Co-immunoprecipitation of protein complexes in human lens epithelial cell (HLEC) demonstrated that AR could association with iNOS in cell; and the interaction distance of AR-iNOS was 6.50 ± 0.22 nm detected by FRET. This study exhibited a direct inhibition interaction between AR and iNOS in HLECs. It is the first report of inhibition interaction between AR and iNOS, suggesting a new pathophysiological mechanism and providing a new insight into the therapeutic mechanism of DC.